Status:
COMPLETED
Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study
Lead Sponsor:
University of Science and Technology, Yemen
Conditions:
Chemotherapy-induced Oral Mucositis
Eligibility:
All Genders
14-83 years
Phase:
PHASE2
Brief Summary
This study was designed to investigate the effect of Gum Arabic (GA) on cancer patients to prevent chemotherapy-induced oral mucositis. Cancer patients who will receive chemotherapy were divided into ...
Eligibility Criteria
Inclusion
- Patients whom well diagnosed with cancer in any stage were eligible for enrolment if chemotherapy is part of their treatment plan.
Exclusion
- Patients were excluded if
- they had received recent previous chemotherapy or radiotherapy,
- they had oral mucositis or periodontitis,
- there is evidence of any systemic diseases.
Key Trial Info
Start Date :
October 26 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
386 Patients enrolled
Trial Details
Trial ID
NCT03348241
Start Date
October 26 2015
End Date
August 1 2016
Last Update
November 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.